Søren E. Bjørn - Concepedia

Author

Søren E. Bjørn

Also Known As

Henning R. Stennicke, Henrik Agersø, S BJORN, S Bjørn, S E Bjørn, S. Bjorn, S. E. BJØRN, S. E. Bjorn, S. E. Bjørn, S.E. BJØRN

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)Technical University of Denmark University of Copenhagen Aarhus University Ørsted (Denmark)

About

Søren E. Bjørn is an author at Novo Nordisk (Denmark) specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	785
2	Natural Sciences	10	10	669
3	Engineering	2	2	76
4	Health Sciences	1	1	97
5	Allergy	1	1	70

Søren E. Bjørn

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. Søren K. Moestrup, Shumao Cui, Henrik Vorum, Journal of Clinical Investigation GlycobiologyGlycoprotein 330PathologyCellular PharmacologyPharmacotherapy	1995	341
Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model Ida Hilden, Brian Lauritzen, Brit B. Sørensen, Blood	2012	147
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide Jais Rose Bjelke, Lene Hansen, Lars C. Petersen, Blood	2011	136
A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models Henning R. Stennicke, Marianne Kjalke, Ditte M. Karpf, Blood	2013	114
Antifungal activity of chitin‐binding PR‐4 type proteins from barley grain and stressed leaf Jørn Hejgaard, Susanne Jacobsen, Søren E. Bjørn, FEBS Letters	1992	102
Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells Kirsten Drejer, V. Kruse, U. D. Larsen, Diabetes Tyrosine KinaseGlycobiologyInsulin SignalingInsulin AnaloguesReceptor Tyrosine Kinase	1991	97
Effect of Leukocyte Proteinases on Tissue Factor Pathway Inhibitor Lars C. Petersen, Søren E. Bjørn, Ole Nordfang Thrombosis and Haemostasis	1992	85
Inhibitory Properties of Separate Recombinant Kunitz‐Type‐Protease‐Inhibitor Domains from Tissue‐Factor‐Pathway Inhibitor Lars C. Petersen, Søren E. Bjørn, Ole H. Olsen, European Journal of Biochemistry Protein FunctionSignal TransductionSignaling PathwayBiochemistryMedicine	1996	82
Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation‐enhancing LPS‐induced cytokine release from monocytes P. B. Rasmussen, Søren E. Bjørn, Sven Hastrup, FEBS Letters	1996	75
Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human–murine species compatibility study Lars C. Petersen, Peder Lisby Nørby, Sven Branner, Thrombosis Research HistocompatibilityImmunogeneticsAllergyImmune RegulationImmunology	2004	70

Page 1